Cancer trials: Search results
Results: 152 items found. Showing page 5 of 6.
Refine results
An Open-label, Randomized Phase 3 Study to Evaluate Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Belzutifan (MK-6482) and Lenvatinib (MK-7902), or MK-1308A in Combination With Lenvatinib, Versus Pembrolizumab and Lenvatinib, as First-Line Treatment in Participants With Advanced Clear Cell Renal Cell Carcinoma (ccRCC)
Trial short name: MK-6482-012
Cancer type: Genitourinary
Cancer location: Kidney
Disease stage: Early Cancer
Trial phase: Phase 3
The Multiple OutcoMe EvaluatioN of radiation Therapy Using the MR-linac Study
Trial short name: MOMENTUM
Cancer type: Central Nervous System
Cancer location: Other (Central Nervous System)
Disease stage: Other
Trial phase: Other
An Open-label Randomized Phase 3 Study of Tucatinib in Combination with Trastuzumab and mFOLFOX6 versus mFOLFOX6 given with or without either Cetuximab or Bevacizumab as First-line Treatment for Subjects with HER2+ Metastatic Colorectal Cancer
Trial short name: MOUNTAINEER-03
Cancer type: Gastrointestinal
Cancer location: Gastrointestinal
Disease stage: Early Cancer
Trial phase: Phase 3
MRI- and PET-Predictive-Assay of Treatment Outcome in Cancer of the Cervix
Trial short name: MRI-PET Cervix
Cancer type: Gynecology
Cancer location: Cervix
Disease stage: Early Cancer
Trial phase: Other
Metastatic Tumor Research and Outcomes Network
Trial short name: MTRON
Cancer type: Central Nervous System
Cancer location: Spine
Disease stage: Advanced Cancer
Trial phase: Other
National Clinical Melanoma Database
Trial short name: National Melanoma Database
Cancer type: Melanoma
Cancer location: Melanoma
Disease stage: Early and Advanced Cancer
Trial phase: Other
Testing the Addition of the Immunotherapy Drug Pembrolizumab to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) in Stage III-IV or Recurrent Endometrial Cancer
Trial short name: NRG-GY018
Cancer type: Gynecology
Cancer location: Gynecology
Disease stage: Early Cancer
Trial phase: Phase 3
Letrozole With or Without Paclitaxel and Carboplatin in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Trial short name: NRG-GY019
Cancer type: Gynecology
Cancer location: Gynecology
Disease stage: Early Cancer
Trial phase: Phase 3
OCELOT – Osimertinib then Chemotherapy in EGFR-mutated Lung cancer with Osimertinib Third-line rechallenge
Trial short name: OCELOT
Cancer type: Lung
Cancer location: Lung
Disease stage: Early Cancer
Trial phase: Phase 2
ONC201 for the Treatment of Newly Diagnosed H3 K27M-mutant Diffuse Glioma Following Completion of Radiotherapy: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study
Trial short name: ONC201-108
Cancer type: Central Nervous System
Cancer location: Central Nervous System
Disease stage: Early Cancer
Trial phase: Phase 3
Open Label, Multicenter, Phase II Study of Patients with Treatment Naïve Metastatic Epidermal Growth Factor Receptor (EGFR) Mutation-Positive Non-Small Cell Lung Cancer (NSCLC) with Brain Metastases Randomized to Stereotactic Radiosurgery (SRS) and Osimertinib or Osimertinib Alone
Trial short name: OSIRIS
Cancer type: Lung
Cancer location: Lung
Disease stage: Advanced Cancer
Trial phase: Phase 2
Ovarian Suppression Evaluating Subcutaneous Leuprolide Acetate in Breast Cancer (OVELIA)
Trial short name: OVELIA
Cancer type: Breast
Cancer location: Breast
Disease stage: Early Cancer
Trial phase: Phase 3
Perioperative versus Adjuvant Chemotherapy for Resectable Pancreatic Cancer
Trial short name: PAC.3
Cancer type: Gastrointestinal
Cancer location: Gastrointestinal
Disease stage: Early Cancer
Trial phase: Phase 3
Prostate Advances in Comparative Evidence-Registry
Trial short name: PACE-R
Cancer type: Genitourinary
Cancer location: Prostate
Disease stage: Early Cancer
Trial phase: Other
INVESTIGATING THE POTENTIAL OF SHORT-TERM PATIENT DERIVED XENOGRAFTS FOR PERSONALIZED MEDICINE FOR PATIENTS WITH METASTATIC SOLID TUMORS: A Non-interventional Clinical Trial.
Trial short name: PDXovo
Cancer type: Genitourinary
Cancer location: Genitourinary
Disease stage: Early Cancer
Trial phase:
Paroxysmal Nocturnal Hemoglobinuria (PNH) Registry
Trial short name: PNH Registry
Cancer type: Blood Related
Cancer location: Paroxysmal Nocturnal Hemoglobinuria
Disease stage: Other
Trial phase: Other
A Randomized Phase II Trial Evaluating Hight Dose Rate Brachytherapy and Low Dose Rate Brachytherapy as Monotherapy in Localized Prostate Cancer
Trial short name: PR.19
Cancer type: Genitourinary
Cancer location: Prostate
Disease stage: Early Cancer
Trial phase: Phase 2
A Study of Ablative Therapy for Metastatic Prostate Cancer
Trial short name: PR.20
Cancer type: Genitourinary
Cancer location: Prostate
Disease stage: Advanced Cancer
Trial phase: Phase 3
A Randomized Phase II Study of 177 LuPSMA-617 vs Docetaxel in Patients With Metastatic Castration-Resistant Prostate Cancer and PSMA-Positive Disease
Trial short name: PR.21
Cancer type: Genitourinary
Cancer location: Prostate
Disease stage: Early Cancer
Trial phase: Phase 2
Partial breast re-irradiation using ultra hypofractionation Phase 2 multi- institutional study
Trial short name: PRESERVE
Cancer type: Breast
Cancer location: Breast
Disease stage: Early Cancer
Trial phase:
A Randomized Phase II Trial Comparing Biomarker Directed Therapy Versus Clinician's Choice of Enzalutamide or Docetaxel in Patients With Advanced Prostate Cancer Post Abiraterone
Trial short name: PROTRACT
Cancer type: Genitourinary
Cancer location: Prostate
Disease stage: Early Cancer
Trial phase: Phase 2
An Open-label, Randomized, Phase III Study Comparing 177Lu-PSMA-617 in Combination With Standard of Care, Versus Standard of Care Alone, in Adult Male Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC)
Trial short name: PSMAddition
Cancer type: Genitourinary
Cancer location: Prostate
Disease stage: Early Cancer
Trial phase: Phase 3
A Phase 3 Study of the Hepcidin Mimetic Rusfertide (PTG-300) in Patients with Polycythemia Vera (PTG 300 11)
Trial short name: PTG 300 11
Cancer type: Blood Related
Cancer location: Blood Related
Disease stage: Early Cancer
Trial phase: Phase 3
qBOLD MRI of Glioblastoma Multiforme for Assessment of Tumor Hypoxia
Trial short name: qBOLD in MRI
Cancer type: Central Nervous System
Cancer location: Brain
Disease stage: Early and Advanced Cancer
Trial phase: Other
An Open-Label, Randomized, Phase 3 Study of Linvoseltamab (REGN5458; Anti-BCMA X Anti-CD3 Bispecific Antibody) Versus the Combination of Elotuzumab, Pomalidomide, and Dexamethasone (EPD), in Patients With Relapsed/Refractory Multiple Myeloma (Linker-MM3)
Trial short name: Regen RRMM
Cancer type: Blood Related
Cancer location: Multiple Myeloma
Disease stage: Early Cancer
Trial phase: Phase 3
